Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05397067 · ClinicalTrials.gov registry record · NA

Linkage to Care for Persons with Hep C Infection

A NA study of Substance Use Disorders and Hepatitis C, Chronic, sponsored by Carilion Clinic.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05397067 is a NA study of Substance Use Disorders and Hepatitis C, Chronic that has completed, run by Carilion Clinic. The registered enrollment target is 80 participants, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05397067, a NA study of Substance Use Disorders and Hepatitis C, Chronic, has completed, sponsored by Carilion Clinic.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

Hepatitis C Virus (HCV) infection is an ongoing challenge in the United States, with an estimated 2.4 million individuals living with HCV in 2016. According to the Virginia Department of Health, over 11,500 people were living with HCV infection in 2017 with a rate of 170 reported cases/100,000 adults. This same year, the situation was even more dire in Roanoke City which had a rate of 524/100,000 adults. Treatment with antiviral medication is curative and well tolerated. However, gaps remain in the ability of the health system to engage the most vulnerable patients to start and complete treatment. People with HCV infection usually are unaware of the infection, which allows the disease to progress to liver damage, liver cancer and death if left untreated.At each stage of the screening, testing, and treatment process, there is significant patient loss to follow-up. Drop-off most commonly occurs between diagnosis and the first visit to a treating provider. Key barriers to successful engagement include: 1) communication issues, such as lack of phone or limited phone access; 2) lack of transportation; 3) significant social issues such as poverty; 4) substance use disorder; and 5) a limited understanding of the consequences of untreated HCV infection. In this mixed-method design, the investigators propose a pilot study that will provide education and resources, such as vouchers for phone, transportation, and meals, to the most vulnerable patients that will facilitate engagement in treatment as additional factors that may influence dropout rates are evaluated.

Interventions

  • BEHAVIORAL Peer specialist (PS) and vouchers

Study Locations (1)

Virginia

  • Carilion Clinic - Roanoke

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-07-12
Est. Completion 2025-02-04
Phase NA

Sponsor

Carilion Clinic

45 total trials

What the Registry Record Tells You About NCT05397067

The ClinicalTrials.gov registry entry for NCT05397067 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (84% lower). The listed sponsor is Carilion Clinic, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which Peer specialist (PS) and vouchers is the first listed.

NCT05397067 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT05397067 about?

NCT05397067 is a clinical study titled "Linkage to Care for Persons with Hep C Infection". Hepatitis C Virus (HCV) infection is an ongoing challenge in the United States, with an estimated 2.4 million individuals living with HCV in 2016. According to the Virginia Department of Health, over 11,500 people were living with HCV infection in 2017 with a rate of 170 reported cases/100,000 adult...

What is the current status of trial NCT05397067?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2022-07-12. Estimated completion is 2025-02-04.

What conditions does trial NCT05397067 study?

This clinical trial studies the following conditions: Substance Use Disorders, Hepatitis C, Chronic.

What interventions are being tested in trial NCT05397067?

The interventions under investigation include: Peer specialist (PS) and vouchers (BEHAVIORAL).

Who is sponsoring clinical trial NCT05397067?

This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05397067 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.